MDR for Manufacturers

MDR for Manufacturers

Just three years ago, a deadline extension for the MDR implementation was under discussion, which was desired above all by the manufacturers. The deadlines remained unchanged, which was quickly determined. However, the question of how to stem the upheaval in the medical technology industry remained unanswered.

The biggest concern is probably the lack of notified bodies. Time is running. In May 2019, TÜV Süd was recognized as one of the first notified bodies for MDR (Medical Device Regulation) in Germany. But the projects for the new registration of the products last and faster procedures have their price.

The fundamental problem is that even products already on the market must undergo the new process and do not have any stock protection. Besides, more and more notified bodies throughout Europe are reporting that they will not be certified for the new regulations. QS Zurich (Switzerland) and Lloyd’s Register Quality Assurance (LRQA, Great Britain) only announced in June that they no longer wanted to work as notified bodies under the new regulations.

Guaranteed MDR-UDI Implementation

A lack of time and notified bodies for MDR represents a significant hurdle for medical technology manufacturers. Therefore, the danger of losing sight of other parts of the MDR, like UDI, is prominent. The fact that a main project is also pending can quickly be forgotten due to the current difficulties and the deadlines that still seem far away.

  • Class III and implants: May 2021
  • Classes IIa and IIb: May 2023
  • Class I: May 2025

As early as May 2020, manufacturers will have to report their product master data to EUDAMED. The data must be kept for the long term, at least for the service life of a product. Moreover, the exchange of data is not limited to EUDAMED. Manufacturers must also continue to exchange documents and data with their producers. Due to the new regulations and the exchanges with the European database, however, the process is becoming more complex.

A system that simplifies processes and exchange among each other is, therefore, valuable for all the supply chain players.

More MedTech News